Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Natriuretic Peptide, Brain | 37 | 2021 | 1750 | 3.310 |
Why?
|
Heart Failure | 59 | 2021 | 11882 | 2.490 |
Why?
|
Peptide Fragments | 32 | 2021 | 5143 | 2.290 |
Why?
|
Troponin T | 10 | 2020 | 786 | 1.550 |
Why?
|
Stroke Volume | 22 | 2021 | 5618 | 0.980 |
Why?
|
Ventricular Remodeling | 10 | 2019 | 1281 | 0.940 |
Why?
|
Endothelin-1 | 4 | 2018 | 297 | 0.790 |
Why?
|
Adrenergic beta-Antagonists | 7 | 2019 | 1241 | 0.780 |
Why?
|
Dyspnea | 6 | 2021 | 1352 | 0.740 |
Why?
|
Heart Failure, Systolic | 3 | 2017 | 135 | 0.700 |
Why?
|
Receptors, Cell Surface | 7 | 2015 | 2815 | 0.670 |
Why?
|
Insulin-Like Growth Factor Binding Proteins | 6 | 2020 | 208 | 0.660 |
Why?
|
Troponin I | 7 | 2020 | 659 | 0.640 |
Why?
|
Ventricular Function, Left | 11 | 2020 | 3935 | 0.610 |
Why?
|
Ventricular Dysfunction, Left | 10 | 2020 | 2143 | 0.570 |
Why?
|
Acute Coronary Syndrome | 5 | 2018 | 2186 | 0.550 |
Why?
|
Myocardial Infarction | 6 | 2020 | 11513 | 0.540 |
Why?
|
Cardiovascular Agents | 4 | 2019 | 849 | 0.530 |
Why?
|
Prognosis | 37 | 2020 | 29948 | 0.530 |
Why?
|
Angiography | 3 | 2018 | 1595 | 0.500 |
Why?
|
Cachexia | 1 | 2016 | 202 | 0.470 |
Why?
|
Oxygen Consumption | 2 | 2017 | 1874 | 0.440 |
Why?
|
Echocardiography | 9 | 2020 | 5037 | 0.410 |
Why?
|
Natriuretic Peptides | 1 | 2014 | 156 | 0.410 |
Why?
|
Growth Differentiation Factor 15 | 1 | 2014 | 198 | 0.400 |
Why?
|
Patient Participation | 1 | 2021 | 1445 | 0.380 |
Why?
|
Outpatients | 4 | 2016 | 1596 | 0.380 |
Why?
|
Myocardium | 4 | 2017 | 4765 | 0.370 |
Why?
|
Coronary Artery Disease | 8 | 2020 | 6558 | 0.370 |
Why?
|
Predictive Value of Tests | 21 | 2020 | 15416 | 0.360 |
Why?
|
Coronary Circulation | 1 | 2017 | 1602 | 0.360 |
Why?
|
Echocardiography, Doppler, Pulsed | 1 | 2010 | 68 | 0.340 |
Why?
|
Protein Precursors | 4 | 2016 | 1134 | 0.340 |
Why?
|
Galectin 3 | 4 | 2015 | 239 | 0.320 |
Why?
|
Coronary Stenosis | 4 | 2020 | 803 | 0.320 |
Why?
|
Risk Assessment | 17 | 2019 | 24295 | 0.320 |
Why?
|
Heart Rate | 2 | 2019 | 4207 | 0.320 |
Why?
|
Chronic Disease | 15 | 2018 | 9357 | 0.320 |
Why?
|
Coronary Angiography | 7 | 2019 | 4508 | 0.310 |
Why?
|
Quality of Life | 4 | 2021 | 13476 | 0.290 |
Why?
|
Disease Management | 2 | 2018 | 2533 | 0.290 |
Why?
|
Guideline Adherence | 1 | 2017 | 2234 | 0.270 |
Why?
|
Aged | 56 | 2024 | 171343 | 0.270 |
Why?
|
Middle Aged | 53 | 2024 | 223257 | 0.260 |
Why?
|
Patient Readmission | 3 | 2018 | 3283 | 0.260 |
Why?
|
Prospective Studies | 25 | 2020 | 54871 | 0.250 |
Why?
|
Cardiac Pacing, Artificial | 1 | 2010 | 881 | 0.250 |
Why?
|
Proteomics | 4 | 2020 | 3914 | 0.250 |
Why?
|
Oxygen | 1 | 2017 | 4251 | 0.240 |
Why?
|
Follow-Up Studies | 21 | 2020 | 39309 | 0.240 |
Why?
|
Emergency Service, Hospital | 5 | 2021 | 7871 | 0.240 |
Why?
|
Heart Failure, Diastolic | 2 | 2016 | 77 | 0.240 |
Why?
|
Male | 62 | 2024 | 364142 | 0.230 |
Why?
|
Atrial Natriuretic Factor | 3 | 2015 | 350 | 0.220 |
Why?
|
Electrocardiography | 1 | 2017 | 6408 | 0.220 |
Why?
|
Humans | 84 | 2024 | 766766 | 0.220 |
Why?
|
Acute Disease | 8 | 2021 | 7241 | 0.220 |
Why?
|
Female | 64 | 2024 | 396520 | 0.220 |
Why?
|
Cause of Death | 5 | 2019 | 3716 | 0.200 |
Why?
|
Tetrazoles | 2 | 2019 | 923 | 0.190 |
Why?
|
Cardiovascular Diseases | 8 | 2019 | 15657 | 0.190 |
Why?
|
Electric Countershock | 1 | 2024 | 534 | 0.190 |
Why?
|
ROC Curve | 6 | 2020 | 3620 | 0.180 |
Why?
|
Disease Progression | 11 | 2018 | 13640 | 0.180 |
Why?
|
Medicare | 1 | 2019 | 6820 | 0.180 |
Why?
|
Habits | 1 | 2021 | 148 | 0.170 |
Why?
|
Renal Insufficiency | 2 | 2016 | 811 | 0.170 |
Why?
|
Neprilysin | 2 | 2020 | 487 | 0.160 |
Why?
|
Time Factors | 14 | 2020 | 40149 | 0.160 |
Why?
|
Hyperlipoproteinemias | 1 | 2019 | 20 | 0.160 |
Why?
|
Patient Selection | 2 | 2016 | 4252 | 0.160 |
Why?
|
Angiotensin Receptor Antagonists | 3 | 2020 | 1065 | 0.150 |
Why?
|
Echocardiography, Transesophageal | 1 | 2024 | 1093 | 0.150 |
Why?
|
Sodium Potassium Chloride Symporter Inhibitors | 2 | 2016 | 157 | 0.140 |
Why?
|
Treatment Outcome | 17 | 2019 | 65273 | 0.140 |
Why?
|
Aged, 80 and over | 15 | 2020 | 59550 | 0.140 |
Why?
|
Lipocalins | 2 | 2015 | 160 | 0.140 |
Why?
|
Systole | 2 | 2016 | 935 | 0.140 |
Why?
|
Nutrition Disorders | 1 | 2017 | 203 | 0.140 |
Why?
|
Tissue Survival | 1 | 2017 | 120 | 0.140 |
Why?
|
Apolipoproteins | 1 | 2019 | 328 | 0.140 |
Why?
|
Amyloidosis | 1 | 2024 | 877 | 0.140 |
Why?
|
Acute Kidney Injury | 3 | 2020 | 1946 | 0.130 |
Why?
|
Peripheral Arterial Disease | 2 | 2018 | 1304 | 0.130 |
Why?
|
Nutritional Sciences | 1 | 2017 | 148 | 0.130 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 4 | 2016 | 1514 | 0.130 |
Why?
|
Neurotensin | 1 | 2016 | 59 | 0.130 |
Why?
|
Adrenomedullin | 2 | 2015 | 85 | 0.130 |
Why?
|
Receptors, Interleukin-1 | 2 | 2014 | 260 | 0.130 |
Why?
|
Risk Factors | 16 | 2019 | 74881 | 0.130 |
Why?
|
Cystatin C | 2 | 2014 | 272 | 0.130 |
Why?
|
Catheterization | 2 | 2018 | 1429 | 0.130 |
Why?
|
Catheters | 1 | 2018 | 428 | 0.130 |
Why?
|
Necrosis | 2 | 2017 | 1616 | 0.120 |
Why?
|
Glomerular Filtration Rate | 3 | 2018 | 2232 | 0.120 |
Why?
|
Heart | 2 | 2020 | 4425 | 0.120 |
Why?
|
Blood Proteins | 2 | 2018 | 1194 | 0.120 |
Why?
|
Heart Ventricles | 3 | 2017 | 3832 | 0.120 |
Why?
|
Acetylglucosaminidase | 1 | 2014 | 66 | 0.120 |
Why?
|
Biphenyl Compounds | 2 | 2019 | 1026 | 0.120 |
Why?
|
Severity of Illness Index | 7 | 2019 | 15908 | 0.120 |
Why?
|
Catheterization, Peripheral | 1 | 2018 | 346 | 0.120 |
Why?
|
Troponin | 1 | 2018 | 536 | 0.110 |
Why?
|
Proportional Hazards Models | 6 | 2019 | 12534 | 0.110 |
Why?
|
Calcitonin | 1 | 2015 | 327 | 0.110 |
Why?
|
Immunoassay | 1 | 2017 | 742 | 0.110 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2017 | 10745 | 0.110 |
Why?
|
Limit of Detection | 1 | 2014 | 271 | 0.110 |
Why?
|
Vietnam | 1 | 2014 | 413 | 0.100 |
Why?
|
Patient Care | 1 | 2018 | 629 | 0.100 |
Why?
|
Behavior Therapy | 1 | 2018 | 886 | 0.100 |
Why?
|
Pneumonia, Bacterial | 1 | 2015 | 319 | 0.100 |
Why?
|
Survival Rate | 6 | 2017 | 12825 | 0.100 |
Why?
|
Risk Reduction Behavior | 1 | 2018 | 1120 | 0.100 |
Why?
|
Dizziness | 1 | 2014 | 269 | 0.090 |
Why?
|
Saphenous Vein | 1 | 2014 | 519 | 0.090 |
Why?
|
Ischemic Attack, Transient | 1 | 2016 | 874 | 0.090 |
Why?
|
Fibrinogen | 1 | 2014 | 893 | 0.090 |
Why?
|
Primary Prevention | 1 | 2018 | 1188 | 0.090 |
Why?
|
Graft Occlusion, Vascular | 1 | 2014 | 538 | 0.090 |
Why?
|
Age Factors | 4 | 2018 | 18397 | 0.090 |
Why?
|
Sex Factors | 4 | 2020 | 10619 | 0.090 |
Why?
|
Internationality | 1 | 2015 | 1006 | 0.090 |
Why?
|
Body Mass Index | 2 | 2019 | 13050 | 0.080 |
Why?
|
Feasibility Studies | 1 | 2021 | 5306 | 0.080 |
Why?
|
Terminology as Topic | 1 | 2017 | 1540 | 0.080 |
Why?
|
Apoptosis Regulatory Proteins | 1 | 2015 | 1150 | 0.080 |
Why?
|
Kaplan-Meier Estimate | 6 | 2016 | 6512 | 0.080 |
Why?
|
Myocardial Contraction | 1 | 2014 | 1516 | 0.080 |
Why?
|
Kidney Function Tests | 3 | 2016 | 685 | 0.080 |
Why?
|
United States | 8 | 2021 | 72951 | 0.080 |
Why?
|
Patient Compliance | 1 | 2019 | 2694 | 0.080 |
Why?
|
Randomized Controlled Trials as Topic | 6 | 2016 | 10384 | 0.080 |
Why?
|
Diagnosis, Differential | 3 | 2017 | 12985 | 0.070 |
Why?
|
Cardiology | 1 | 2019 | 1701 | 0.070 |
Why?
|
Health Care Costs | 1 | 2021 | 3242 | 0.070 |
Why?
|
Patient Admission | 1 | 2015 | 1364 | 0.070 |
Why?
|
Ambulatory Care | 2 | 2016 | 2779 | 0.070 |
Why?
|
Pilot Projects | 1 | 2021 | 8728 | 0.070 |
Why?
|
Reproducibility of Results | 4 | 2018 | 20144 | 0.070 |
Why?
|
Comorbidity | 2 | 2019 | 10580 | 0.070 |
Why?
|
Anxiety Disorders | 1 | 2018 | 2744 | 0.070 |
Why?
|
Incidence | 7 | 2019 | 21525 | 0.070 |
Why?
|
Attitude to Health | 1 | 2015 | 2021 | 0.070 |
Why?
|
Hospitalization | 5 | 2021 | 10823 | 0.070 |
Why?
|
Diuretics | 3 | 2016 | 614 | 0.070 |
Why?
|
Reference Values | 1 | 2014 | 4913 | 0.070 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2013 | 1657 | 0.070 |
Why?
|
Endothelium, Vascular | 1 | 2018 | 4424 | 0.070 |
Why?
|
Recovery of Function | 1 | 2016 | 2976 | 0.060 |
Why?
|
Statistics as Topic | 1 | 2012 | 2351 | 0.060 |
Why?
|
Proto-Oncogene Proteins | 2 | 2015 | 4522 | 0.060 |
Why?
|
Motor Activity | 1 | 2015 | 2711 | 0.060 |
Why?
|
Contrast Media | 1 | 2019 | 5329 | 0.060 |
Why?
|
Depressive Disorder | 1 | 2018 | 3715 | 0.060 |
Why?
|
Cohort Studies | 6 | 2019 | 41710 | 0.060 |
Why?
|
Coronary Artery Bypass | 1 | 2014 | 2188 | 0.060 |
Why?
|
Weight Loss | 1 | 2016 | 2712 | 0.060 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2015 | 2902 | 0.060 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2018 | 2306 | 0.060 |
Why?
|
Artificial Intelligence | 1 | 2019 | 2662 | 0.060 |
Why?
|
Membrane Glycoproteins | 1 | 2014 | 3702 | 0.060 |
Why?
|
Kidney Diseases | 1 | 2014 | 2101 | 0.050 |
Why?
|
Acute-Phase Proteins | 2 | 2015 | 251 | 0.050 |
Why?
|
Pulmonary Artery | 1 | 2012 | 1938 | 0.050 |
Why?
|
Coronary Vessels | 1 | 2014 | 3100 | 0.050 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2017 | 4056 | 0.050 |
Why?
|
Antihypertensive Agents | 1 | 2012 | 2030 | 0.050 |
Why?
|
Stents | 1 | 2014 | 3193 | 0.050 |
Why?
|
Sensitivity and Specificity | 4 | 2021 | 14652 | 0.050 |
Why?
|
Ultrasonography | 2 | 2012 | 5992 | 0.050 |
Why?
|
Practice Guidelines as Topic | 1 | 2019 | 7431 | 0.050 |
Why?
|
Exercise | 1 | 2018 | 5945 | 0.050 |
Why?
|
Tomography, Optical Coherence | 1 | 2014 | 2937 | 0.050 |
Why?
|
Research Design | 1 | 2016 | 6207 | 0.040 |
Why?
|
Clinical Trials as Topic | 1 | 2016 | 8045 | 0.040 |
Why?
|
Survival Analysis | 3 | 2019 | 10100 | 0.040 |
Why?
|
Adult | 9 | 2020 | 223307 | 0.040 |
Why?
|
Massachusetts | 3 | 2018 | 8891 | 0.040 |
Why?
|
Obesity | 2 | 2019 | 13090 | 0.040 |
Why?
|
Cross-Sectional Studies | 3 | 2018 | 26310 | 0.040 |
Why?
|
Kidney Failure, Chronic | 1 | 2012 | 2505 | 0.040 |
Why?
|
Physicians | 1 | 2017 | 4591 | 0.040 |
Why?
|
Standard of Care | 2 | 2016 | 569 | 0.040 |
Why?
|
Pharmacological Phenomena | 1 | 2019 | 11 | 0.040 |
Why?
|
Kidney | 1 | 2015 | 7074 | 0.040 |
Why?
|
Area Under Curve | 2 | 2015 | 1638 | 0.040 |
Why?
|
Analysis of Variance | 2 | 2019 | 6214 | 0.040 |
Why?
|
Decision Trees | 1 | 2021 | 508 | 0.040 |
Why?
|
Odds Ratio | 3 | 2015 | 9661 | 0.040 |
Why?
|
Principal Component Analysis | 1 | 2020 | 949 | 0.030 |
Why?
|
Depression | 1 | 2017 | 8228 | 0.030 |
Why?
|
Inflammation | 1 | 2017 | 10860 | 0.030 |
Why?
|
Multivariate Analysis | 3 | 2016 | 12064 | 0.030 |
Why?
|
Prevalence | 3 | 2018 | 15835 | 0.030 |
Why?
|
Economics, Hospital | 1 | 2018 | 207 | 0.030 |
Why?
|
Mortality | 2 | 2018 | 2910 | 0.030 |
Why?
|
Cost Savings | 1 | 2021 | 902 | 0.030 |
Why?
|
Adaptor Proteins, Vesicular Transport | 1 | 2016 | 301 | 0.030 |
Why?
|
Lipoproteins, HDL | 1 | 2019 | 677 | 0.030 |
Why?
|
Retrospective Studies | 6 | 2020 | 81635 | 0.030 |
Why?
|
Adiponectin | 1 | 2020 | 1121 | 0.030 |
Why?
|
Neointima | 1 | 2014 | 133 | 0.030 |
Why?
|
Endpoint Determination | 1 | 2016 | 592 | 0.030 |
Why?
|
Confidence Intervals | 1 | 2019 | 2921 | 0.030 |
Why?
|
Angiotensin II Type 1 Receptor Blockers | 1 | 2016 | 428 | 0.030 |
Why?
|
Intercellular Adhesion Molecule-1 | 1 | 2017 | 1131 | 0.030 |
Why?
|
Aging | 1 | 2012 | 8731 | 0.030 |
Why?
|
Solubility | 1 | 2015 | 1078 | 0.030 |
Why?
|
Blood Chemical Analysis | 1 | 2015 | 434 | 0.030 |
Why?
|
Creatinine | 1 | 2019 | 1917 | 0.030 |
Why?
|
Animals | 2 | 2017 | 168930 | 0.030 |
Why?
|
Drug Monitoring | 1 | 2019 | 962 | 0.030 |
Why?
|
Drug Combinations | 1 | 2019 | 2085 | 0.030 |
Why?
|
International Classification of Diseases | 1 | 2018 | 935 | 0.030 |
Why?
|
Calcitonin Gene-Related Peptide | 1 | 2015 | 327 | 0.030 |
Why?
|
Vasodilator Agents | 1 | 2016 | 988 | 0.020 |
Why?
|
Cardiomyopathies | 1 | 2024 | 2059 | 0.020 |
Why?
|
Mass Spectrometry | 1 | 2019 | 2198 | 0.020 |
Why?
|
Digoxin | 1 | 2012 | 246 | 0.020 |
Why?
|
Drug Substitution | 1 | 2014 | 292 | 0.020 |
Why?
|
Hyperplasia | 1 | 2014 | 1150 | 0.020 |
Why?
|
Receptors, Virus | 1 | 2014 | 652 | 0.020 |
Why?
|
Interleukin-17 | 1 | 2017 | 923 | 0.020 |
Why?
|
Patient Care Planning | 1 | 2016 | 904 | 0.020 |
Why?
|
Echocardiography, Doppler | 1 | 2014 | 899 | 0.020 |
Why?
|
Galectins | 1 | 2013 | 295 | 0.020 |
Why?
|
Electric Impedance | 1 | 2014 | 791 | 0.020 |
Why?
|
Heart-Assist Devices | 1 | 2020 | 1287 | 0.020 |
Why?
|
Peroxidase | 1 | 2012 | 610 | 0.020 |
Why?
|
Chi-Square Distribution | 1 | 2015 | 3432 | 0.020 |
Why?
|
Quality Indicators, Health Care | 1 | 2018 | 1804 | 0.020 |
Why?
|
C-Reactive Protein | 1 | 2020 | 3853 | 0.020 |
Why?
|
Activities of Daily Living | 1 | 2016 | 2429 | 0.020 |
Why?
|
Young Adult | 1 | 2014 | 59939 | 0.020 |
Why?
|
Up-Regulation | 1 | 2016 | 4142 | 0.020 |
Why?
|
Cholesterol, LDL | 1 | 2016 | 2392 | 0.020 |
Why?
|
Linear Models | 1 | 2016 | 5874 | 0.020 |
Why?
|
Dietary Supplements | 1 | 2018 | 3429 | 0.020 |
Why?
|
Atrial Fibrillation | 1 | 2024 | 5182 | 0.020 |
Why?
|
Boston | 1 | 2018 | 9346 | 0.010 |
Why?
|
Referral and Consultation | 1 | 2018 | 3618 | 0.010 |
Why?
|
Models, Biological | 1 | 2020 | 9461 | 0.010 |
Why?
|
Quality of Health Care | 1 | 2018 | 4306 | 0.010 |
Why?
|
Genetic Testing | 1 | 2016 | 3591 | 0.010 |
Why?
|
Gene Expression | 1 | 2015 | 7585 | 0.010 |
Why?
|
Hemodynamics | 1 | 2012 | 4188 | 0.010 |
Why?
|
Registries | 1 | 2018 | 8351 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2018 | 14762 | 0.010 |
Why?
|
Electronic Health Records | 1 | 2019 | 4880 | 0.010 |
Why?
|
Health Status | 1 | 2012 | 4087 | 0.010 |
Why?
|
Intensive Care Units | 1 | 2012 | 3799 | 0.010 |
Why?
|
Phenotype | 1 | 2015 | 16724 | 0.010 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2016 | 16044 | 0.010 |
Why?
|